Holding types
Countries
Sectors
Analyst ratings
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FAQ
- What is GERM ETF?
- Does GERM pay dividends?
- What stocks are in GERM ETF?
- What is the current assets under management for GERM?
- What is GERM average volume?
- What is GERM expense ratio?
- What is GERM inception date?
What is GERM ETF?
The GERM ETF is an exchange-traded fund that focuses on companies in the German market. It offers investors exposure to a diverse range of sectors, including technology, finance, and manufacturing. This fund aims to track the performance of German stocks, providing a convenient way to invest in Germany's economy.
Does GERM pay dividends?
Yes, the Amplify Treatments, Testing and Advancements ETF does pays dividends, with
the most recent payment being
$0.09
per share. The last ex-dividend date was on 27 June 2024, and the next ex-dividend date has not been announced yet
What stocks are in GERM ETF?
As of today, Amplify Treatments, Testing and Advancements ETF inlcudes 57 holdings, with 53 of them being companies from 6 different countries and 1 sectors. The most weighted holdings are Alnylam Pharmaceuticals (11.39%), Laboratory Corporation of America Holdings (7.2%) and Quest Diagnostics Incorporated (6.61%)
What is the current assets under management for GERM?
Assets under management of Amplify Treatments, Testing and Advancements ETF is $9 M
What is GERM average volume?
Average volume of Amplify Treatments, Testing and Advancements ETF is $1680
What is GERM expense ratio?
Expense ratio of Amplify Treatments, Testing and Advancements ETF is 0.68%
What is GERM inception date?
Inception date of Amplify Treatments, Testing and Advancements ETF is 18 June 2020